
Pharma Pulse 4/14/25: Four Ways to Increase Speed to Therapy, What Does the End of DEI Mean For SDOH efforts? & more
The latest news for pharma industry insiders.
The key strategies for reducing or eliminating post-prescription abandonment.
The end of federal diversity, equity and inclusion programs in the federal government may have a ripple effect on social determinants of health efforts.
Tariffs on pharmaceuticals would hurt patients and drugs should be exempt from these levies, AstraZeneca Plc’ Chairman Michel Demaré said.
The "Personalized Medicine Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033" report has been added to ResearchAndMarkets.com's offering. The market is expected to reach US $1 trillion by 2033 from US $546.97 billion in 2024, with a CAGR of 7.05% from 2025 to 2033.
Hyfe's CEO Tamsin Chislett recently spoke to 
We’re thrilled to be featured, and even more excited about what’s ahead.
👀 Curious? Catch the full story here: 
Have news you want us to share in Pharma Pulse? Reach out to Editor 
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.




